STAT May 23, 2024
Top of the morning to you. I’m filling in for Ed Silverman this morning, which means you’re getting Brooklyn instead of the Pharmalot compound, Barry’s tea instead of flavored coffee, and most shockingly, adorable cats. I know. But I can still line up some listening material for the morning news. I know, we are all eagerly awaiting the return of our beloved Pharmalot, but let’s get to it.
Cytokinetics did a deal with Royalty Pharma, the biotech firm that has become a huge success by buying up small shares of other companies’ drugs, to secure up to $575 million in funding, STAT reports. Investors hate it, and the stock is off 14% in early morning trading. One reason...
Today's Sponsors
Today's Sponsor